Bleeding during urologic surgery can lead to transfusions and major complications. The POISE-3 tested prophylaxis in at-risk ...

Tranexamic acid (TXA) failed to reduce the need for red blood cell (RBC) transfusion following surgery for liver cancer, including colorectal liver metastases, the placebo-controlled HeLiX trial ...

February 21, 2011 (San Diego, California) — A low dose of the synthetic antifibronolytic agent tranexamic acid (TA) decreases the amount of blood loss and the need for blood transfusions during ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, tranexamic acid was linked with reduced perioperative blood loss and transfusions for ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

The use of adjunctive topical tranexamic acid (TXA) showed benefits in significantly reducing postoperative bleeding with second intention healing, or allowing wounds to heal naturally without sutures ...

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid may be indicated for the prevention of heterotopic ossification. Patients undergoing surgery for ...

Adults who are having surgery in an operating theatre where there is any risk of bleeding and the procedure will breach the skin or mucous membrane receive tranexamic acid. The following measures can ...

Prior results with the drug in other surgical settings have been mixed ...